Havens Advisors’s Audentes Therapeutics, Inc BOLD Stock Holding History

Havens Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-26,572	Closed	-$1.59M	–	38
2019 Q4	$1.59M	Buy	+26,572	New	+$997K	1.39%	21

Havens Advisors's BOLD Position: Q1 2020 in Review

Havens Advisors sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 26,572 shares — an estimated $1.59M sold.

Havens Advisors first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $1.59M in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Havens Advisors reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Havens Advisors sold 26,572 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $1.59M.
Havens Advisors first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Havens Advisors's Audentes Therapeutics, Inc position peaked at $1.59M in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Havens Advisors's 13F filing for Q1 2020, filed 21 Apr 2020.